Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Kohn

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|January 30, 1990
Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cellsE C Kohn, L A Liotta, E Schiffmann
Angiogenesis|January 1, 1997
New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12L Masiero, W D Figg, E C Kohn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
Clinical implications of using molecular diagnostics for ovarian cancersE C Kohn, S Romano, J-M Lee
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 7, 2004
Promising directions for the diagnosis and management of gynecological cancersE C Kohn, G B Mills, L Liotta
International Journal of Cancer|August 19, 1991
An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1C P Evans, D S Walsh, E C Kohn
Cancer Research|September 15, 1990
Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatideV S Zabrenetzky, E C Kohn, D D Roberts
Bailliere'S Best Practice & Research. Clinical Obstetrics & Gynaecology|January 6, 2001
Angiogenesis in ovarian cancerM R Brown, J O Blanchette, E C Kohn
Experimental Cell Research|July 10, 1997
Regulation of cellular tyrosine phosphorylation by stimulatory and inhibitory muscarinic acetylcholine receptorsR Alessandro, A Pugnaloni, G Biagini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2013
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignanciesJ-M Lee, J A Ledermann, E C Kohn
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Proteomic analysis for early detection of ovarian cancer: a realistic approach?E V Stevens, L A Liotta, E C Kohn
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|January 30, 1990
Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cellsE C Kohn, L A Liotta, E Schiffmann
Angiogenesis|January 1, 1997
New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12L Masiero, W D Figg, E C Kohn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
Clinical implications of using molecular diagnostics for ovarian cancersE C Kohn, S Romano, J-M Lee
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 7, 2004
Promising directions for the diagnosis and management of gynecological cancersE C Kohn, G B Mills, L Liotta
International Journal of Cancer|August 19, 1991
An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1C P Evans, D S Walsh, E C Kohn
Cancer Research|September 15, 1990
Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatideV S Zabrenetzky, E C Kohn, D D Roberts
Bailliere'S Best Practice & Research. Clinical Obstetrics & Gynaecology|January 6, 2001
Angiogenesis in ovarian cancerM R Brown, J O Blanchette, E C Kohn
Experimental Cell Research|July 10, 1997
Regulation of cellular tyrosine phosphorylation by stimulatory and inhibitory muscarinic acetylcholine receptorsR Alessandro, A Pugnaloni, G Biagini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2013
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignanciesJ-M Lee, J A Ledermann, E C Kohn
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Proteomic analysis for early detection of ovarian cancer: a realistic approach?E V Stevens, L A Liotta, E C Kohn
Pageof 8